Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Results 1 - 20 of 186 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar WJJS (53.18) Submitted: 9/1/2015 3:46:15 PM : Outperform Start Price: $36.41 LLY Score: +78.86

Consistant through the years

Recs

0
Member Avatar PaperTrail (57.84) Submitted: 2/22/2015 7:55:55 AM : Underperform Start Price: $70.89 LLY Score: -22.70

Silly

Recs

0
Member Avatar afewgoodstocks11 (< 20) Submitted: 2/18/2014 6:56:52 PM : Outperform Start Price: $34.92 LLY Score: +82.38

Div. (Yield) $1.96 (3.6%)
Current Yield . . . . . 5.37%

Recs

0
Member Avatar theActuary (64.76) Submitted: 1/14/2014 8:00:24 AM : Outperform Start Price: $49.47 LLY Score: +58.16

LLY woot

Recs

0
Member Avatar knockripper (22.25) Submitted: 11/15/2013 9:20:56 AM : Outperform Start Price: $48.27 LLY Score: +60.66

Great Company, health care reform.

Recs

0
Member Avatar jmpeavler (< 20) Submitted: 8/12/2013 5:54:29 PM : Underperform Start Price: $52.61 LLY Score: -40.09

most of their drugs have gone genetic. A couple of new ones (diabetes and dementia) don't seem to be making much progress with testing. good dependable dividends.

Recs

1
Member Avatar Teacherman333 (92.91) Submitted: 6/1/2013 1:14:36 PM : Outperform Start Price: $50.52 LLY Score: +42.14

For reference point and to allow for comments by others. As of the end of March, 2013.

ROE 31.07%
Trailing PE 12.78
PB 3.92
Div yield 3.60%

Recs

1
Member Avatar 6sigmaford (22.99) Submitted: 11/15/2012 12:02:53 PM : Outperform Start Price: $41.84 LLY Score: +51.17

Diabetes will be around a long time and so will Lilly.

Recs

0

Recs

0
Member Avatar GVA1 (< 20) Submitted: 10/14/2012 9:58:32 AM : Outperform Start Price: $46.09 LLY Score: +40.98

Surprising success in Alzheimer's portfolio

Recs

0
Member Avatar TMFBiologyFool (97.11) Submitted: 10/12/2012 12:25:24 PM : Underperform Start Price: $45.73 LLY Score: -41.97

Over exuberance for Alzheimer's program.

Recs

0
Member Avatar FoolWithFive (99.41) Submitted: 7/25/2012 12:04:25 PM : Outperform Start Price: $38.88 LLY Score: +64.36

They are the heart and soul of indianapolis. This company does great things for the state of Indiana and health care!

Recs

1
Member Avatar einzling44 (21.86) Submitted: 5/15/2012 4:04:46 AM : Underperform Start Price: $36.58 LLY Score: -77.81

cap spending ahead

Recs

0
Member Avatar slih (< 20) Submitted: 1/26/2012 12:58:31 AM : Outperform Start Price: $34.88 LLY Score: +87.84

veternary products; retained corporate brainpower

Recs

0
Member Avatar fooluser17 (< 20) Submitted: 1/19/2012 2:04:19 PM : Outperform Start Price: $35.10 LLY Score: +84.47

Dividend rockstar, most numbers are good. Probably make this one 1%.

Recs

0
Member Avatar jesseangels (< 20) Submitted: 1/13/2012 7:41:59 PM : Outperform Start Price: $35.09 LLY Score: +82.90

Undervalued. Target ~50$.

Recs

0
Member Avatar guinness4life (73.21) Submitted: 12/21/2011 6:21:56 PM : Outperform Start Price: $36.50 LLY Score: +67.29

Long this. Gorgeous value stock with great dividend. I got in a few months ago. Get in the next time a drug misses approval.

Recs

0
Member Avatar Divlover (59.47) Submitted: 12/8/2011 4:09:44 PM : Outperform Start Price: $34.03 LLY Score: +82.74

Possible Alzhiemer drug in the works and a nice dividend.

Recs

0
Member Avatar SearchS (< 20) Submitted: 12/6/2011 9:27:59 PM : Outperform Start Price: $34.32 LLY Score: +83.11

Promising drugs in the pipeline...

Recs

0
Member Avatar birdup (43.89) Submitted: 12/6/2011 7:06:47 PM : Outperform Start Price: $34.32 LLY Score: +83.11

Cramer

Featured Broker Partners